Concepedia

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults

Issaka Sagara, Sara A. Healy, Mahamadoun H. Assadou, Erin E. Gabriel, Mamady Koné, Kourane Sissoko, Intimbeye Tembiné, Merepen A. Guindo, M’Bouye Doucoure, Karamoko Niaré,

The Lancet Infectious Diseases · 2018 · 103 citations · 21 references

DOI

Concepts

References

21

Fitting Linear Mixed-Effects Models Using <b>lme4</b>

Douglas M. Bates, Martin Mächler, Benjamin M. Bolker et al. · Journal of Statistical Software · 2015 · 85.6K citations · Full text

, , +15

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu, Ruth D. Ellis, Donna Shaffer et al. · PLoS ONE · 2008 · 454 citations · Full text

, , +13

The principles of disease elimination and eradication

Walter R. Dowdle · PubMed · 1998 · 425 citations

, , +14

Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.

A.N. Vermeulen, T. Ponnudurai, Pascal Beckers et al. · The Journal of Experimental Medicine · 1985 · 359 citations · Full text

, , +17

Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.

P J Barr, Kerry Green, Helen L. Gibson et al. · The Journal of Experimental Medicine · 1991 · 226 citations · Full text

, , +17